Axxess

The post-acute tech company Axxess is partnering with Eazewell to reduce the burden on families after a loved one dies. The

Axxess, the leading global technology platform for care in the home, has entered a strategic partnership with the National Partnership for Healthcare and Hospice Innovation (NPHI), the leading voice for nonprofit hospice and advanced illness care provider

Many organizations think they have a revenue problem. In reality, they have a visibility problem. The biggest financial losses in home-based care are not coming from major system failures or compliance issues. They are happening quietly, every day, inside

Axxess, the leading global technology platform transforming how care is delivered in the home, has partnered with Eazewell, an AI-powered life-event execution platform, to help hospice providers better support families during and after the end-of-life jou

Home health organizations are under constant pressure to do more. More patients. More visits. More documentation requirements. More workforce challenges. More operational complexity. And most organizations aren't struggling because they lack data. They're

The CMS-mandated moratorium has created understandable concern across the care at home industry, but for existing providers the moratorium creates a rare opportunity to strengthen their position in the market and prepare for accelerated growth once enroll

Axxess intelligence has redefined what's possible for care at home organizations by delivering AI-powered insights and clinical support directly inside the workflows care teams use every day. Below are standout features and strategic workflows that showca

Home health leaders ask a lot of questions every day. Are we fully staffed? Are clinicians completing documentation on time? Are we on track to meet productivity goals? Will we hit our financial targets this month? All of those questions matter. But there

Artificial intelligence (AI) is everywhere in healthcare conversations right now. But for hospice leaders facing staffing shortages, growing administrative demands, and ongoing reimbursement pressures, the question is not whether AI is the future. It's wh